Ansgar Rieke

454 total citations
13 papers, 297 citations indexed

About

Ansgar Rieke is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ansgar Rieke has authored 13 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Ansgar Rieke's work include HIV/AIDS Research and Interventions (6 papers), HIV Research and Treatment (5 papers) and HIV/AIDS drug development and treatment (4 papers). Ansgar Rieke is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), HIV Research and Treatment (5 papers) and HIV/AIDS drug development and treatment (4 papers). Ansgar Rieke collaborates with scholars based in Germany, Switzerland and Estonia. Ansgar Rieke's co-authors include Christoph Ozdoba, Jürgen K. Rockstroh, Gerd Fätkenheuer, Christian Hoffmann, Christoph Wyen, Christoph Zubler, A. Arnold, Mark Oette, Pascal Senn and Dirk Schürmann and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and AIDS.

In The Last Decade

Ansgar Rieke

13 papers receiving 292 citations

Peers

Ansgar Rieke

ONCOL

VIROL

EPIDE

PFM

Thomas Buhk Germany

Ke Hong China

Elizabeth Laidlaw United States

Anna Fournier France

Selami Aykut Temiz Türkiye

Michael Meilinger Austria

Sarah Pett Australia

A Felici Italy

F. Fily France

Dirk Mentzer Germany

Thomas Buhk Germany

Ansgar Rieke

93 ×0.8

173 ×1.6

ONCOL

74 ×1.0

VIROL

56 ×0.8

EPIDE

126 ×1.9

PFM

Citations per year, relative to Ansgar Rieke Ansgar Rieke (= 1×) peers Thomas Buhk

Countries citing papers authored by Ansgar Rieke

Since Specialization

Citations

This map shows the geographic impact of Ansgar Rieke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ansgar Rieke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ansgar Rieke more than expected).

Fields of papers citing papers by Ansgar Rieke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ansgar Rieke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ansgar Rieke. The network helps show where Ansgar Rieke may publish in the future.

Co-authorship network of co-authors of Ansgar Rieke

This figure shows the co-authorship network connecting the top 25 collaborators of Ansgar Rieke. A scholar is included among the top collaborators of Ansgar Rieke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ansgar Rieke. Ansgar Rieke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Stephan, Christoph, Christoph D. Spinner, Ansgar Rieke, et al.. (2024). Effectiveness, safety, and patient‐reported outcomes of emtricitabine/tenofovir alafenamide‐based regimens for the treatment of HIV‐1 infection: Final 24‐month results from the prospective German TAFNES cohort study. HIV Medicine. 26(2). 239–251. 1 indexed citations

Kaddu‐Mulindwa, Dominic, Jürgen Rissland, Sigrun Smola, et al.. (2021). IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study. HIV Medicine. 23(5). 564–569. 3 indexed citations

Audebert, Franz, Cornelia Feiterna‐Sperling, Daniel Gillor, et al.. (2021). Not Recommended, But Done: Breastfeeding with HIV in Germany. AIDS Patient Care and STDs. 35(2). 33–38. 22 indexed citations

Wedemeyer, Heiner, Ansgar Rieke, Albrecht Stoehr, et al.. (2021). Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry. Liver International. 41(5). 949–955. 7 indexed citations

Kittner, Jens M., Jörg Wiltink, Thomas Thomaidis, et al.. (2015). Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohort. Infection. 43(3). 299–305. 8 indexed citations

Hentrich, Marcus, Marcel Berger, Christoph Wyen, et al.. (2012). Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter Study. Journal of Clinical Oncology. 30(33). 4117–4123. 68 indexed citations

Petersen, J., Thomas A. Lutz, Axel Baumgarten, et al.. (2012). 1149 PREDICTIVE FACTORS FOR NONRESPONSE IN GENOTYPE 2/3 INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE SETTING. Journal of Hepatology. 56. S454–S454. 1 indexed citations

Rieke, Ansgar & Christoph Ozdoba. (2011). Computed tomography angiography (CTA) to prove circulatory arrest for the diagnosis of brain death in the context of organ transplantation. Swiss Medical Weekly. 141(3940). w13261–w13261. 21 indexed citations

Rieke, Ansgar, et al.. (2011). Low-Dose Temporal Bone CT in Infants and Young Children: Effective Dose and Image Quality. American Journal of Neuroradiology. 32(8). 1375–1380. 38 indexed citations

10.

Wyen, Christoph, Christian Hoffmann, Jürgen K. Rockstroh, et al.. (2004). Progressive Multifocal Leukencephalopathy in Patients on Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(2). 1263–1268. 54 indexed citations

11.

Oette, Mark, Martin Däumer, JK Rockstroh, et al.. (2004). Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany.. PubMed. 9(5). 273–8. 24 indexed citations

12.

Lichterfeld, Mathias, Hans Dieter Nischalke, Frank Bergmann, et al.. (2002). Long‐term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapy. HIV Medicine. 3(1). 37–43. 19 indexed citations

13.

Rockstroh, Jürgen K., Frank Bergmann, Ansgar Rieke, et al.. (2000). Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. AIDS. 14(9). 1181–1185. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact